191 related articles for article (PubMed ID: 19754754)
1. The role of neutrophils in the development and outcome of zygomycosis in haematological patients.
Pagano L; Valentini CG; Fianchi L; Caira M
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():33-6. PubMed ID: 19754754
[TBL] [Abstract][Full Text] [Related]
2. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes.
Gil-Lamaignere C; Simitsopoulou M; Roilides E; Maloukou A; Winn RM; Walsh TJ
J Infect Dis; 2005 Apr; 191(7):1180-7. PubMed ID: 15747255
[TBL] [Abstract][Full Text] [Related]
3. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
Chamilos G; Lewis RE; Kontoyiannis DP
Clin Infect Dis; 2008 Aug; 47(4):503-9. PubMed ID: 18611163
[TBL] [Abstract][Full Text] [Related]
4. [Invasive zygomycosis: notably in diabetes mellitus and iron overload].
Kullberg BJ; van 't Wout JW
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2603-5. PubMed ID: 18161259
[TBL] [Abstract][Full Text] [Related]
5. Cytokines and fungal infections.
Antachopoulos C; Roilides E
Br J Haematol; 2005 Jun; 129(5):583-96. PubMed ID: 15916680
[TBL] [Abstract][Full Text] [Related]
6. Host defenses against zygomycetes.
Roilides E; Kontoyiannis DP; Walsh TJ
Clin Infect Dis; 2012 Feb; 54 Suppl 1():S61-6. PubMed ID: 22247447
[TBL] [Abstract][Full Text] [Related]
7. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.
Cordonnier C; Botterel F; Ben Amor R; Pautas C; Maury S; Kuentz M; Hicheri Y; Bastuji-Garin S; Bretagne S
Clin Microbiol Infect; 2009 Jan; 15(1):81-6. PubMed ID: 19154482
[TBL] [Abstract][Full Text] [Related]
8. Zygomycosis--current epidemiological aspects.
Glöckner A; Vehreschild JJ; Cornely OA
Mycoses; 2007; 50 Suppl 1():50-5. PubMed ID: 17394610
[TBL] [Abstract][Full Text] [Related]
9. Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy.
Grigg A; Slavin M
Transpl Infect Dis; 2008 Feb; 10(1):3-12. PubMed ID: 17605732
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation of zygomycosis.
Mantadakis E; Samonis G
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():15-20. PubMed ID: 19754751
[TBL] [Abstract][Full Text] [Related]
11. [Zygomycetes and zygomycosis in the new era of antifungal therapies].
Torres-Narbona M; Guinea J; Muñoz P; Bouza E
Rev Esp Quimioter; 2007 Dec; 20(4):375-86. PubMed ID: 18563211
[TBL] [Abstract][Full Text] [Related]
12. Zygomycosis in the 1990s in a tertiary-care cancer center.
Kontoyiannis DP; Wessel VC; Bodey GP; Rolston KV
Clin Infect Dis; 2000 Jun; 30(6):851-6. PubMed ID: 10852735
[TBL] [Abstract][Full Text] [Related]
13. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
14. Incidence of zygomycosis in transplant recipients.
Cuenca-Estrella M; Bernal-Martinez L; Isla G; Gomez-Lopez A; Alcazar-Fuoli L; Buitrago MJ
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():37-40. PubMed ID: 19754755
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
[TBL] [Abstract][Full Text] [Related]
16. [Risk factor for invasive zygomycosis in patients with hematologic malignancies].
Rickerts V; Böhme A; Just-Nübling G
Mycoses; 2002; 45 Suppl 1():27-30. PubMed ID: 12073559
[TBL] [Abstract][Full Text] [Related]
17. Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis.
Orciuolo E; Stanzani M; Canestraro M; Galimberti S; Carulli G; Lewis R; Petrini M; Komanduri KV
J Leukoc Biol; 2007 Oct; 82(4):839-48. PubMed ID: 17626149
[TBL] [Abstract][Full Text] [Related]
18. Changing epidemiology of an emerging infection: zygomycosis.
Meis JF; Chakrabarti A
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():10-4. PubMed ID: 19754750
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
20. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management.
Kontoyiannis DP; Lewis RE
Infect Dis Clin North Am; 2006 Sep; 20(3):581-607, vi. PubMed ID: 16984870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
